Pinto, L. C. . (2020) “BCR-ABL kinase domain mutations analysis in chronic myeloid leukaemia patients that are not responsive to imatinib mesylate”, HSJ. Itajubá, Brasil, 10(4), pp. 77–84. doi: 10.21876/rcshci.v10i4.994.